Cargando…
Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer
BACKGROUND: Noninvasive biomarkers predicting immune checkpoint inhibitor (ICI) response are urgently needed. We evaluated the predictive value of pretreatment neutrophil-to-lymphocyte ratio (NLR), smoking history, smoking intensity, BMI and programmed death ligand 1 (PD-L1) expression in non-small-...
Autores principales: | Newman, James, Preeshagul, Isabel, Kohn, Nina, Devoe, Craig, Seetharamu, Nagashree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162145/ https://www.ncbi.nlm.nih.gov/pubmed/34084210 http://dx.doi.org/10.2217/lmt-2020-0024 |
Ejemplares similares
-
Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer
por: Lee, Chung-Shien, et al.
Publicado: (2020) -
New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
por: Seetharamu, Nagashree, et al.
Publicado: (2017) -
Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies
por: Olazagasti, Coral, et al.
Publicado: (2020) -
Implementing physician education to increase lung cancer screening uptake
por: Olazagasti, Coral, et al.
Publicado: (2023) -
Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer
por: Olazagasti, Coral, et al.
Publicado: (2022)